Update on Clinical Data with Regimens Inhibiting Angiogenesis and Epidermal Growth Factor Receptor for Patients with Newly Diagnosed Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Update on Clinical Data with Regimens Inhibiting Angiogenesis and Epidermal Growth Factor Receptor for Patients with Newly Diagnosed Metastatic Colorectal Cancer

Published:2007-12 Issue: Volume:7 Page:S21-S27
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Cohen Deirdre J.,Hochster Howard S.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference34 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Targeted therapy in colorectal cancer;Rajpal;Clin Adv Hematol Oncol,2006

3. Avastin [package insert],2007

4. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971

5. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo;Kim;Nature,1993

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer;Journal of Oncology Pharmacy Practice;2020-02-17

2. Dipeptidyl peptidase-4 inhibitors: Anti-diabetic drugs with potential effects on cancer;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2019-01

3. Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation;Stem Cells International;2018

4. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia;Neurobiology of Disease;2014-11

5. Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept;Gastroenterology Research and Practice;2014